Lars Zender

EDUCATION AND ACADEMIC POSITIONS

1995-2002 Medical School, Medical School Hannover, Hannover, Germany.

2002 Medical Approbation (M.D.) by the State of Lower Saxony, Germany.

2002 Doctor of Medicine (Dr. med), Grade: “Summa cum laude” (Excellent).

2002-2004 Resident and physician scientist in Internal Medicine/Gastroenterology/GIOncology,

Medical School Hannover, Hannover, Germany.

2004-2005 Postdoctoral Fellow (Emmy Noether Phase I stipend of the German Research Foundation), Laboratory of Dr. Scott W. Lowe, Cold Spring Harbor Laboratory, Cold Spring Harbor, USA.

2005-2007 Clinical Fellow, Laboratory of Dr. Scott W. Lowe, Cold Spring Harbor Laboratory, Cold Spring Harbor, USA.

2008-2012 Group leader (Emmy Noether Research Group and Helmholtz University Research Goup) at the Helmholtz Centre for Infection Research and Medical School Hannover.

2008-2012 Project Leader “Liver Regeneration” within the Rebirth Cluster of Excellence for Regenerative Sciences, Medical School Hannover.

2008-2012 Fellow in Gastroenterology, Hepatology & Endocrinology, Hannover Medical School, Hannover, Germany.

2009 Assistant Professor (W1) for Experimental Gastrointestinal Oncology at Medical School Hannover.

2010-present Project Leader within the Transregional Collaborative Research Center SFB/TRR77 “Liver Cancer-From Molecular Pathogenesis to Targeted Therapy”, University of Heidelberg and Medical School Hannover.

2010-present Partner and Project leader within the EU/FP7 network “HEPTROMICGenomic predictors and oncogenic drivers in hepatocellular carcinoma” .

2010-present Adjunct Assistant Professor, Cold Spring Harbor Laboratory, Cold Spring Harbor, USA.

2012-present Full professor (W3) and Head of the Division of Translational Gastrointestinal Oncology, Department of Internal Medicine I, University Hospital Tübingen.

2012-present Member of the scientific advisory board of the Fritz Lipman institute for age research in Jena.

2012-present Project Leader within the Collaborative Research Center (SFB) 685 “Immunotherapy”.

2013-present Executive board member and Scientific Director of the Comprehensive Cancer Center Tübingen (Südwestdeutsches Tumorzentrum).

2013-present Member of the foundation council of the Ludwig Hiermeier Stiftung for applied Cancer Reserarch.

2013-present Group leader “Translational Gastrointestinal Oncology Group”, German Cancer Research Center (DKFZ), Heidelberg.

2013-present Consultant for Gastrointestinal Oncology and Head of Gastrointestinal Oncology within the Comprehensive Cancer Center Tübingen and Department of Internal Medicine I (Director: Prof. N.P. Malek).